<DOC>
	<DOCNO>NCT00805207</DOCNO>
	<brief_summary>Increased plasma triglyceride concentration common feature metabolic abnormality associate obesity major risk factor cardiovascular disease . Obesity major risk factor two condition appear increase prevalence woman : polycystic ovary syndrome sleep disorder breathing . PCOS affect 5-8 % woman . Sleep disorder breathe affect 10 % woman . Obstructive sleep apnea common cause sleep disorder breathe particularly prevalent obese woman PCOS ( ~50 % ) . Both PCOS OSA augment increase plasma TG concentration associate obesity , effect polycystic ovary syndrome obstructive sleep apnea plasma TG concentration appear additive . The mechanism responsible adverse effect plasma TG metabolism know . The primary goal project , therefore , determine mechanism responsible increase plasma triglyceride concentration obese woman polycystic ovary syndrome obstructive sleep apnea . It general hypothesis alteration hormonal milieu characteristic two condition , least part , responsible increase plasma TG concentration obese woman condition . Furthermore , hypothesize hormonal aberration characteristic two condition particularly harmful obese , compare lean , woman . The effect PCOS skeletal muscle protein metabolism also know . However , sex hormone think important regulator muscle protein turnover suggest muscle protein metabolism likely affect PCOS . We examine determine effect individual sex hormone muscle protein metabolism hypothesize testosterone administration stimulate muscle protein metabolism estrogen progesterone administration inhibit muscle protein metabolism .</brief_summary>
	<brief_title>Sex Steroids , Sleep , Metabolic Dysfunction Women</brief_title>
	<detailed_description />
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Women age 1875 year men 4575 year Healthy lean , overweight obese woman ( BMI 1840 kg/m2 ) obese men ( BMI 3040 kg/m2 ) Obese woman ( BMI 3040 kg/m2 ) OSA PCOS Pregnant , lactating , peri postmenopausal woman exclude study potential confounding influence factor potential ethical concern ( pregnant woman ) Women take medication know affect substrate metabolism evidence significant organ dysfunction ( e.g . impaired glucose tolerance , diabetes mellitus , liver disease , hypo hyperthyroidism ) PCOS OSA Severe hypertriglyceridemia ( fast plasma TG concentration &gt; 400 mg/dl ) Subjects OSA apneahypopnea index ( AHI ) score &gt; 30 ( total number obstructive event divide total hour sleep ) exclude instructed seek medical care</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>PCOS</keyword>
	<keyword>sleep apnea</keyword>
	<keyword>obese</keyword>
	<keyword>VLDL metabolism</keyword>
	<keyword>isotope tracer</keyword>
	<keyword>woman</keyword>
</DOC>